Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health
Open Access
- 11 August 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 2, 61
Abstract
Glutamine together with glucose is essential for body’s homeostasis. It is the most abundant amino acid and is involved in many biosynthetic, regulatory and energy production processes. Several membrane transporters which differ in transport modes, ensure glutamine homeostasis by coordinating its absorption, reabsorption and delivery to tissues. These transporters belong to different protein families, are redundant and ubiquitous. Their classification, originally based on functional properties, has recently been associated with the SLC nomenclature. Function of glutamine transporters is studied in cells over-expressing the transporters or, more recently in proteoliposomes harboring the proteins extracted from animal tissues or over-expressed in microorganisms. The role of the glutamine transporters is linked to their transport modes and coupling with Na+ and H+. Most transporters share specificity for other neutral or cationic amino acids. Na+-dependent co-transporters efficiently accumulate glutamine while antiporters regulate the pools of glutamine and other amino acids. The most acknowledged glutamine transporters belong to the SLC1, 6, 7 and 38 families. The members involved in the homeostasis are the co-transporters B0AT1 and the SNAT members 1, 2, 3, 5 and 7; the antiporters ASCT2, LAT1 and 2. The last two are associated to the ancillary CD98 protein. Some information on regulation of the glutamine transporters exist, which, however, need to be deepened. No information at all is available on structures, besides some homology models obtained using similar bacterial transporters as templates. Some models of rat and human glutamine transporters highlight very similar structures between the orthologues. Moreover the presence of glycosylation and/or phosphorylation sites located at the extracellular or intracellular faces has been predicted. ASCT2 and LAT1 are over-expressed in several cancers, thus representing potential targets for pharmacological intervention.Keywords
This publication has 213 references indexed in Scilit:
- Strategies of Bacterial Over Expression of Membrane Transporters Relevant in Human Health: The Successful Case of the Three Members of OCTN SubfamilyMolecular Biotechnology, 2012
- Intestinal peptidases form functional complexes with the neutral amino acid transporter B0AT1Biochemical Journal, 2012
- Identification of SLC38A7 (SNAT7) Protein as a Glutamine Transporter Expressed in NeuronsJournal of Biological Chemistry, 2011
- Human endogenous retroviruses and multiple sclerosis: Innocent bystanders or disease determinants?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- The structural basis of secondary active transport mechanismsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2011
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolismNature, 2009
- Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesisProceedings of the National Academy of Sciences, 2007
- Over-production of Proteins inEscherichia coli: Mutant Hosts that Allow Synthesis of some Membrane Proteins and Globular Proteins at High LevelsJournal of Molecular Biology, 1996
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993